Brodt P, Lala P K
Cell Immunol. 1984 Apr 1;84(2):427-32. doi: 10.1016/0008-8749(84)90116-3.
Changes in the host T-lymphocyte subsets during the development of spontaneous mammary carcinomas in C3H/HeJ mice were analyzed on the basis of Lyt antigenic markers in retired breeder females prior to and following tumor appearance. Lymphocytes derived from various host lymphoid organs as well as from the tumor site were labeled either directly with 125I-conjugated monoclonal anti-Lyt antibodies or by a sandwich labeling technique with monoclonal anti-Lyt antibodies and 125I-conjugated anti-mouse Ig. The relative incidence of the various Lyt subsets was determined by radioautography. It was found that the overall incidence of T cells within the tumors increased during tumor progression. The incidence of the Lyt-1-, 2+ subset was very high (congruent to 20%) initially within the small, young tumors, and then this incidence declined progressively as the tumor increased in size to 0-5% in older and larger tumors, with a concomitant increase of the Lyt-1+, 2- subset. High levels of Lyt-1-, 2+ lymphocytes were also detected within the thymus (up to 41%) as well as the regional draining nodes (up to 7%) of animals bearing small newly detected tumors and could also occasionally be found in old clinically "tumor-free" control animals. These results support the earlier proposal based on functional studies with primary chemically induced tumors and in hosts bearing transplanted tumors that Lyt-1-, 2+ lymphocytes may play an immunoregulatory role in the early stages of tumor development possibly as facilitators of tumor growth.
基于Lyt抗原标记,对C3H/HeJ小鼠自发性乳腺癌发生发展过程中宿主T淋巴细胞亚群的变化进行了分析,研究对象为肿瘤出现前后的老龄繁殖雌鼠。从宿主的各种淋巴器官以及肿瘤部位获取的淋巴细胞,要么直接用125I标记的抗Lyt单克隆抗体进行标记,要么采用抗Lyt单克隆抗体和125I标记的抗小鼠Ig的夹心标记技术进行标记。通过放射自显影确定各种Lyt亚群的相对发生率。结果发现,肿瘤进展过程中肿瘤内T细胞的总体发生率增加。在小的早期肿瘤中,Lyt-1-、2+亚群的发生率最初非常高(约20%),然后随着肿瘤增大,这一发生率逐渐下降,在较大的老龄肿瘤中降至0 - 5%,同时Lyt-1+、2-亚群增加。在新发现的小肿瘤动物的胸腺(高达41%)以及引流区域淋巴结(高达7%)中也检测到高水平的Lyt-1-、2+淋巴细胞,在老龄临床“无肿瘤”对照动物中偶尔也能发现。这些结果支持了早期基于对原发性化学诱导肿瘤以及荷移植瘤宿主的功能研究提出的观点,即Lyt-1-、2+淋巴细胞可能在肿瘤发展的早期阶段发挥免疫调节作用,可能作为肿瘤生长的促进因子。